{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T17:11:53Z","timestamp":1750871513971},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T00:00:00Z","timestamp":1394064000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1038\/hr.2014.23","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T07:01:54Z","timestamp":1394089314000},"page":"526-532","source":"Crossref","is-referenced-by-count":9,"title":["Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study"],"prefix":"10.1038","volume":"37","author":[{"name":"for the OlmeSartan Calcium Antagonists Randomized (OSCAR) Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Matsui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shokei","family":"Kim-Mitsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomio","family":"Jinnouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Jinnouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kikuo","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,6]]},"reference":[{"key":"BFhr201423_CR1","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.110.152892","volume":"56","author":"JM Flack","year":"2010","unstructured":"Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH Jr, Hall WD, Jones WE, Kountz DS, Lea JP, Nasser S, Nesbitt SD, Saunders E, Scisney-Matlock M, Jamerson KA . Management of high blood pressure in blacks: an update of the international society on hypertension in blacks consensus statement. Hypertension 2010; 56: 780\u2013800.","journal-title":"Hypertension"},{"key":"BFhr201423_CR2","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ . The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560\u20132572.","journal-title":"JAMA"},{"key":"BFhr201423_CR3","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"K Jamerson","year":"2008","unstructured":"Jamerson K, Weber MA, Bakris GL, Dahlof B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ . Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. New Engl J Med 2008; 359: 2417\u20132428.","journal-title":"New Engl J Med"},{"key":"BFhr201423_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0025-6196(11)60993-2","volume":"82","author":"LA Blauwet","year":"2007","unstructured":"Blauwet LA, Hayes SN, McManus D, Redberg RF, Walsh MN . Low rate of sex-specific result reporting in cardiovascular trials. Mayo Clin Proc 2007; 82: 166\u2013170.","journal-title":"Mayo Clin Proc"},{"key":"BFhr201423_CR5","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1089\/jwh.2008.0992","volume":"18","author":"C Ljungman","year":"2009","unstructured":"Ljungman C, Mortensen L, Kahan T, Manhem K . Treatment of mild to moderate hypertension by gender perspective: a systematic review. J Womens Health (Larchmt) 2009; 18: 1049\u20131062.","journal-title":"J Womens Health (Larchmt)"},{"key":"BFhr201423_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/hr.2009.60","volume":"32","author":"H Ogawa","year":"2009","unstructured":"Ogawa H, Kim-Mitsuyama S, Jinnouchi T, Matsui K, Arakawa K . Rationale, design and patient baseline characteristics of olmesartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. Gov no. NCT00134160). Hypertens Res 2009; 32: 575\u2013580.","journal-title":"Hypertens Res"},{"key":"BFhr201423_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.amjmed.2011.12.010","volume":"125","author":"H Ogawa","year":"2012","unstructured":"Ogawa H, Kim-Mitsuyama S, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K . Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients. Am J Med 2012; 125: 981\u2013990.","journal-title":"Am J Med"},{"key":"BFhr201423_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7326\/0003-4819-126-10-199705150-00002","volume":"126","author":"F Gueyffier","year":"1997","unstructured":"Gueyffier F, Boutitie F, Boissel JP, Pocock S, Coope J, Cutler J, Ekbom T, Fagard R, Friedman L, Perry M, Prineas R, Schron E . Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med 1997; 126: 761\u2013767.","journal-title":"Ann Intern Med"},{"key":"BFhr201423_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMoa021716","volume":"348","author":"LM Wing","year":"2003","unstructured":"Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, Johnston CI, McNeil JJ, Macdonald GJ, Marley JE, Morgan TO, West MJ . A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. New Engl J Med 2003; 348: 583\u2013592.","journal-title":"New Engl J Med"},{"key":"BFhr201423_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0895-7061(03)01008-2","volume":"17","author":"ME Safar","year":"2004","unstructured":"Safar ME, Smulyan H . Hypertension in women. Am J Hypertens 2004; 17: 82\u201387.","journal-title":"Am J Hypertens"},{"key":"BFhr201423_CR11","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMsr077003","volume":"357","author":"R Wang","year":"2007","unstructured":"Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM . Statistics in medicine\u2014reporting of subgroup analyses in clinical trials. New Engl J Med 2007; 357: 2189\u20132194.","journal-title":"New Engl J Med"},{"key":"BFhr201423_CR12","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1056\/NEJMp068070","volume":"354","author":"SW Lagakos","year":"2006","unstructured":"Lagakos SW . The challenge of subgroup analyses-reporting without distorting. New Engl J Med 2006; 354: 1667\u20131669.","journal-title":"New Engl J Med"},{"key":"BFhr201423_CR13","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","unstructured":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002; 288: 2981\u20132997.","journal-title":"JAMA"},{"key":"BFhr201423_CR14","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1097\/01.hjh.0000249692.96488.46","volume":"24","author":"A Zanchetti","year":"2006","unstructured":"Zanchetti A, Julius S, Kjeldsen S, McInnes GT, Hua T, Weber M, Laragh JH, Plat F, Battegay E, Calvo-Vargas C, Cieslinski A, Degaute JP, Holwerda NJ, Kobalava J, Pedersen OL, Rudyatmoko FP, Siamopoulos KC, Storset O . Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the value trial. J Hypertens 2006; 24: 2163\u20132168.","journal-title":"J Hypertens"},{"key":"BFhr201423_CR15","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jacc.2008.05.025","volume":"52","author":"ES Kim","year":"2008","unstructured":"Kim ES, Carrigan TP, Menon V . Enrollment of women in national heart, lung, and blood institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion. J Am Coll Cardiol 2008; 52: 672\u2013673.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr201423_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/jwh.2010.2469","volume":"20","author":"SE Geller","year":"2011","unstructured":"Geller SE, Koch A, Pellettieri B, Carnes M . Inclusion, analysis, and reporting of sex and race\/ethnicity in clinical trials: have we made progress? J Womens Health 2011; 20: 315\u2013320.","journal-title":"J Womens Health"},{"key":"BFhr201423_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/hr.2008.26","volume":"32","author":"T Kohro","year":"2009","unstructured":"Kohro T, Yamazaki T . Cardiovascular clinical trials in Japan and controversies regarding prospective randomized open-label blinded end-point design. Hypertens Res 2009; 32: 109\u2013114.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr201423.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201423","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201423.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:14:06Z","timestamp":1684430046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr201423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["BFhr201423"],"URL":"https:\/\/doi.org\/10.1038\/hr.2014.23","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"type":"print","value":"0916-9636"},{"type":"electronic","value":"1348-4214"}],"subject":[],"published":{"date-parts":[[2014,3,6]]}}}